As of 2025-07-19, the Relative Valuation of Impel Neuropharma Inc (IMPL) is (309.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 USD, the upside of Impel Neuropharma Inc based on Relative Valuation is -128451.2%.
The range of the Relative Valuation is (298.83) - (431.85) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 18.7x | 13.1x |
| Forward P/E multiples | 12.6x - 21.3x | 13.7x |
| Fair Price | (298.83) - (431.85) | (309.45) |
| Upside | -124045.2% - -179217.0% | -128451.2% |
| Date | P/E |